Meeder Asset Management Inc. Reduces Stake in Encompass Health Corporation $EHC

by · The Cerbat Gem

Meeder Asset Management Inc. cut its holdings in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 61.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 29,301 shares of the company’s stock after selling 47,612 shares during the period. Meeder Asset Management Inc.’s holdings in Encompass Health were worth $3,722,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in EHC. Citizens National Bank Trust Department purchased a new position in Encompass Health during the 3rd quarter valued at $26,000. Newbridge Financial Services Group Inc. lifted its position in shares of Encompass Health by 112.5% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company’s stock worth $52,000 after purchasing an additional 225 shares during the period. Global Retirement Partners LLC boosted its stake in shares of Encompass Health by 23.0% during the 3rd quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after purchasing an additional 84 shares in the last quarter. Employees Retirement System of Texas purchased a new position in shares of Encompass Health during the second quarter valued at about $57,000. Finally, Parkside Financial Bank & Trust raised its stake in Encompass Health by 179.5% in the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after buying an additional 307 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on EHC shares. KeyCorp upped their target price on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. UBS Group upped their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Finally, Wall Street Zen lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $142.86.

Check Out Our Latest Report on EHC

Encompass Health Price Performance

Shares of NYSE:EHC opened at $102.89 on Monday. The business has a fifty day moving average price of $110.79 and a 200-day moving average price of $116.97. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.14 and a quick ratio of 1.14. The company has a market capitalization of $10.35 billion, a PE ratio of 19.45, a PEG ratio of 1.66 and a beta of 0.74. Encompass Health Corporation has a 1-year low of $90.67 and a 1-year high of $127.99.

Encompass Health (NYSE:EHC – Get Free Report) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The company had revenue of $136.30 million for the quarter. As a group, equities analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.19 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Read More

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).